Publicaciones en colaboración con investigadores/as de St George's, University of London (15)

2023

  1. Asthma management and control in children, adolescents, and adults in 25 countries: a Global Asthma Network Phase I cross-sectional study

    The Lancet Global Health, Vol. 11, Núm. 2, pp. e218-e228

2022

  1. The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I study

    European Respiratory Journal, Vol. 60, Núm. 3

2021

  1. Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial

    Bone Marrow Transplantation, Vol. 56, Núm. 6, pp. 1413-1421

2020

  1. Use of ov16-based serology for post-elimination surveillance of onchocerciasis in Ecuador

    American Journal of Tropical Medicine and Hygiene, Vol. 103, Núm. 4, pp. 1569-1571

2018

  1. NF-κB Activity Initiates Human ESC-Derived Neural Progenitor Cell Differentiation by Inducing a Metabolic Maturation Program

    Stem Cell Reports, Vol. 10, Núm. 6, pp. 1766-1781

2016

  1. Drug-loaded erythrocytes: On the road toward marketing approval

    Drug Design, Development and Therapy, Vol. 10, pp. 665-676

  2. NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming

    Cell Reports, Vol. 14, Núm. 8, pp. 1883-1891

2014

  1. Therapeutic options in relapsed or refractory peripheral T-cell lymphoma

    Cancer Treatment Reviews, Vol. 40, Núm. 9, pp. 1080-1088

2013

  1. Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: A prospective randomized trial from the lymphoma working party of the European Group for Blood and Marrow Transplantation

    Journal of Clinical Oncology, Vol. 31, Núm. 13, pp. 1624-1630

2012

  1. International seminar on the red blood cells as vehicles for drugs

    Expert Opinion on Biological Therapy

2011

  1. Clinical scores and patient risk stratification in non-ST elevation acute coronary syndrome

    International Journal of Cardiology, Vol. 146, Núm. 2, pp. 219-224

2010

  1. Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome

    Atherosclerosis, Vol. 209, Núm. 1, pp. 300-305

2009

  1. Implications of the European organisation for research and treatment of cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care

    Clinical Drug Investigation, Vol. 29, Núm. 8, pp. 491-513

2006

  1. Relation of circulating C-reactive protein to progression of aortic valve stenosis

    American Journal of Cardiology, Vol. 97, Núm. 1, pp. 90-93

2003

  1. Marcadores de inflamación y estratificacin de riesgo en pacientes con síndrome coronario agudo: Diseño del estudio SIESTA (Sytemic Inflammation Evaluation in patients with non-ST segment elevation Acute coronary syndromes)

    Revista Espanola de Cardiologia, Vol. 56, Núm. 4, pp. 389-395